News & Events

News

All categories

Earnings

Press Release

All years

2020

2019

2018

2017

2016

2015

2014

Affimed to Present at the UBS Global Healthcare Conference – New York

May 12, 2015

Affimed N.V. Announces Pricing of Public Offering of Common Stock

May 6, 2015

Affimed N.V. Announces Proposed Public Offering of Common Stock

May 4, 2015

Affimed Announces Financial Results for Fourth Quarter and Year End 2014

March 25, 2015

Affimed Announces Fourth Quarter and Year End 2014 Financial Results Conference Call

March 18, 2015

Affimed to Present at the 27th Annual ROTH Conference

March 3, 2015

Affimed to Present at the BIO CEO & Investor Conference and at the Leerink Partners Global Healthcare Conference

February 3, 2015

Affimed Appoints Dr. Martin Treder as Chief Scientific Officer

January 20, 2015

Affimed Receives EUR 2.4 million ($3 million) Research Grant from German Government to Fund Trispecific Abs

January 7, 2015

Affimed Presents Final Data for AFM13 Phase 1 Trial at ASH

December 8, 2014

Events

All

Scientific

Investors

29May

ASCO 2020 Annual Meeting

May 29 - June 2, 2020 (TBD)

22Jun

AACR Virtual Annual Meeting II

June 22 - 24, 2020 (virtual)

25Aug

Innate Killer Summit 2020

August 25 - 26, 2020 (San Diego, USA)
Presenter: Joachim Koch

Webcasts
More events

We use cookies to give you the best experience on our website. By continuing to use it, you agree with it.